The primary aim is to study the one-year outcome (remission) of late-life depressive-, anxiety- and somatic symptom disorders jointly. ROMGPS specifically aims to estimate the impact of comorbidity between affective disorders, the treatment components delivered, and age-related characteristics on treatment effectiveness. Such knowledge will guide the development of more effective and age-specific treatment strategies.
Researchers
Richard Oude Voshaar, Rob van den Brink, and ROMGPS study group
Date
2015-01-01
till date
Participants
Patients referred to geriatric psychiatric outpatient departments, who are diagnosed at intake with a unipolar mood disorder, anxiety disorder (GAD, panic disorder, agoraphobia, or social phobia) or somatoform disorder.